Dr. Reddy’s Shares Spike After Morgan Stanley, BofA Raises Price Target Post Q1 Results - NDTV Profit
NDTV Profitarrow_outwardDr. Reddy’s Q1 net inches up amid decline in generics sales to U.S.
The Hinduarrow_outwardDr. Reddy's Laboratories shares in focus as Q1 net profit jumps 2% YoY. Should you invest?
The Economic Timesarrow_outwardDr Reddy’s PAT rises 2% despite record quarterly revenues in Q1FY26
Times of Indiaarrow_outwardDr Reddy's Laboratories share price in focus post Q1 results: Buy or sell? - Mint
Mintarrow_outwardStocks To Buy Today: Infosys, Persistent Systems, Tata Consumer, Godrej Agrovet, Dr Reddy's | Share Price Target - ET Now
ET Nowarrow_outwardHow to trade Dr Reddys Labs shares after muted performance in Q1FY26? Know what analysts say - Zee Business
Zee Businessarrow_outwardDr Reddy's Laboratories Q1 print misses target; brokerages split on outlook - Business Standard
Business Standardarrow_outwardDr Reddy's Laboratories shares in focus after Q1; should you buy, sell or hold? - Moneycontrol
Moneycontrolarrow_outwardQ1 Results Highlights: Tata Consumer Products consolidated profit surges over 15% YoY to ₹334 crore, revenue up 10% - Upstox
Upstoxarrow_outwardDr. Reddy's Laboratories Q1 Results: Net Profit Rises 2% YoY to Rs 1,418 Crore, Revenue Grows 11% - Goodreturns
Goodreturnsarrow_outwardDr Reddy’s Q1FY26: Profit below estimates; revenue up 11.4%- Key 5 takeaways - financialexpress.com
Financialexpress.comarrow_outwardDr Reddy's Q1 FY26 results: PAT up 2% at Rs 1,418 crore, revenue climbs 11% - Business Today
Business Todayarrow_outwardDr. Reddy’s Laboratories Share Price Drops After USFDA Issues Seven Observations - Samco
Samcoarrow_outwardDRREDDY Outlook for the Week (July 21, 2025 – July 25, 2025) - Equitypandit
Equitypanditarrow_outwardDr. Reddy's Laboratories Shows Shift to Bullish Outlook Amid Mixed Performance - MarketsMojo
MarketsMojoarrow_outwardDr Reddy’s Stock Declines 2% As Citi Cuts Target Price Doubting Earnings In Upcoming Quarters - BW Businessworld
BW Businessworldarrow_outwardDr Reddy's shares drop 2% as Citi trims target price; sees 26% downside - TradingView
TradingViewarrow_outwardNomura lists four factors that will drive growth for Dr. Reddy's beyond gRevlimid - CNBC TV18
CNBC TV18arrow_outwardDr. Reddy’s Labs stock in focus amid FDA inspection report, Q4 results - The New Indian Express
The New Indian Expressarrow_outwardNew Product Launches Save the Day for Dr Reddy’s in Q4, But Margins Remain a Sour Pill - outlookbusiness.com
Outlookbusiness.comarrow_outwardThe Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Yearly Results Are Out And Analysts Have Published New Forecasts - simplywall.st
Simplywall.starrow_outwardExplained: Why Dr Reddy's share price cracked 6% in early trade - India Today
India Todayarrow_outward
Dr Reddy Share Price close
- 2025-07-24 12:00 event
- 23 sourceslanguage
- 200+ ads_click
- 3 days ago schedule